NCT00793273View on ClinicalTrials.gov

Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.

CompletedOBSERVATIONAL

Enrollment

1,074

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Effectiveness and safety data collection in connection with the use of the drug Levemir® in daily clinical practice

Trial Locations (1)

CH-8050

Zurich

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00793273 - Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes. | Biotech Hunter | Biotech Hunter